ANI Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in the United States with operations in Baudette, Minnesota; Princeton, New Jersey; and East Windsor, New Jersey. The company's core business involves developing, manufacturing, and marketing branded and generic prescription pharmaceutical products. Its technical capabilities span hormone manufacturing, solid and liquid dose manufacturing, controlled substances, contract manufacturing, and packaging.
The company operates across therapeutic areas including ophthalmology, nephrology, and acute care. It has a specific focus on rare diseases through its lead asset, Purified Cortrophin Gel, which is indicated for conditions with high unmet medical need. The team comprises between 501 and 1,000 employees.
